RG
Rajesh Gupta
About Rajesh Gupta
Data last updated:
Rajesh Gupta is an Additional Director at Uv Lifecare Limited (since 2026), Director at Dallas Drugs Private Limited (since 2018) and Director at Dallas Formulations Private Limited (since 2006), and holds 4 more current directorships. The companies operate in Pharma, Ecommerce and Internet and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹51.89 Cr; the largest is Uv Lifecare Limited at ₹29.35 Cr (FY 2025). Earlier, Rajesh Gupta was a Director at Embark Life Science Private Limited (2005–2009) and Director at Maxwell Health Care Limited (2010–2012) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 19 Jan 2026 | 2021 | ₹29.35 Cr (FY 2025) | Active | |
| Director | 29 Sep 2018 | 2012 | ₹12.01 Cr (FY 2025) | Active | |
| Director | 16 Jan 2006 | 2000 | ₹10.53 Cr (FY 2025) | Active | |
| Director | 03 Feb 2026 | 2026 | Active | ||
| Director | 03 Feb 2026 | 2026 | Active | ||
| Designated Partner | 19 Jul 2024 | 2024 | Active | ||
| Director | 23 Aug 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Apr 2005 | 2005 | ₹26,289 (FY 2025) | Active | |
| Director | 03 May 2010 | 1995 | Under Process Of Striking Off | ||
| Director | 17 Apr 2017 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajesh Gupta
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Gupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Gupta
Rajesh Gupta currently holds 7 directorships: Uv Lifecare Limited (Additional Director, since 19 Jan 2026, revenue ₹29.35 Cr (FY 2025)); Dallas Drugs Private Limited (Director, since 29 Sep 2018, revenue ₹12.01 Cr (FY 2025)); Dallas Formulations Private Limited (Director, since 16 Jan 2006, revenue ₹10.53 Cr (FY 2025)); Dauket Pharma Private Limited (Director, since 03 Feb 2026); Delantero Pharma Private Limited (Director, since 03 Feb 2026); and 2 more.
Rajesh Gupta was first appointed on 05 Apr 2005 as Director at Embark Life Science Private Limited. The most recent appointment on record is 03 Feb 2026 at Delantero Pharma Private Limited.
The 3 current companies of Rajesh Gupta that report revenue have a combined latest revenue of ₹51.89 Cr: Uv Lifecare Limited ₹29.35 Cr (FY 2025); Dallas Drugs Private Limited ₹12.01 Cr (FY 2025); Dallas Formulations Private Limited ₹10.53 Cr (FY 2025).
Rajesh Gupta held 3 earlier board appointments: Embark Life Science Private Limited (Director, 05 Apr 2005 to 10 Jun 2009); Maxwell Health Care Limited (Director, 03 May 2010 to 17 May 2012); Galen Infrastructure Limited (Director, from 17 Apr 2017).
The current boards of Rajesh Gupta's companies include Manan Kathuria (Uv Lifecare Limited), Ramesh Kathuria (Uv Lifecare Limited), Seema Kathuria (Uv Lifecare Limited), Suhani Kathuria (Uv Lifecare Limited), Anil Kumar (Dallas Drugs Private Limited), Mukesh Kumar (Dallas Formulations Private Limited), among others.